Histological grade, p53, HER2 and hormone receptor status of synchronous bilateral breast carcinoma
- 1 April 2002
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer
- Vol. 9 (2), 127-133
- https://doi.org/10.1007/bf02967577
Abstract
Histological grade and tumor biology remain important predictors of the clinical behavior of breast carcinomas. We analyzed the clinicopathological characteristics and tumor biology with regard to histological grade (HG), p53, HER2 and hormone receptor status to address this question.Keywords
This publication has 19 references indexed in Scilit:
- Evaluation of histopathological criteria for identifying nodenegative breast cancer witn high risk of early recurrence in the nsas-bc protocol studyBreast Cancer, 2000
- Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour?European Journal Of Cancer, 1998
- Bilateral Breast Carcinoma Versus Unilateral DiseaseAmerican Journal of Clinical Oncology, 1997
- Breast-conserving therapy for Stage I-II synchronous bilateral breast carcinomaCancer, 1997
- Histologic grade and p53 immunoreaction as indicators of early recurrence of node-negative breast cancerJapanese Journal of Clinical Oncology, 1997
- Comparison of p53 gene abnormalities in bilateral and unilateral breast cancerCancer, 1995
- p53 Mutations and c‐erbB‐2 Amplification in Intraductal and Invasive Breast Carcinomas of High Histologic GradeJapanese Journal of Cancer Research, 1993
- Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast CancerJapanese Journal of Cancer Research, 1991
- Immunohistochemical Study on Overexpression of c‐erbB‐2 Protein in Human Breast Cancer: Its Correlation with Gene Amplification and Long‐term Survival of PatientsJapanese Journal of Cancer Research, 1990
- Breast cancer genetics in an oncology clinic: 328 consecutive patientsCancer Genetics and Cytogenetics, 1986